Novartis says operating profit to grow again ahead of Sandoz spin off
The Swiss drugmaker reported full-year core operating income was broadly flat at $16.7 billion.
Source link
- Russia-Ukraine war: List of key events, day 343
- Iron ore prices could rally as one leading producer remains reluctant to share, analyst says
